Elevance Health Inc
ELV#80 of 134 by buybacksNYSE · Healthcare · Healthcare Plans · USA
elevancehealth.comBuybacks · TTM to Jun 2026$2.71Blatest four quarters
Buyback yield3.0%repurchases ÷ market cap
Dividends · TTM to Jun 2026$1.51Bdividend yield 1.7%
Shareholder yield4.7%buybacks + dividends ÷ market cap
Shares outstanding · 5 yr−11.2%218M shares (2026)
Buybacks ÷ free cash flow43%payout incl. dividends 67%
Fiscal-year detail
From the cash-flow statement as reported, in USD. Negative repurchases mean net share issuance.
| Fiscal year | Repurchases | Dividends | Free cash flow |
|---|---|---|---|
| FY2025Dec 2025 | $2.60B | $1.53B | $3.17B |
| FY2024Dec 2024 | $2.90B | $1.51B | $4.55B |
| FY2023Dec 2023 | $2.68B | $1.40B | $6.76B |
| FY2022Dec 2022 | $2.32B | $1.23B | $7.25B |
| FY2021Dec 2021 | $1.90B | $1.10B | $7.28B |
| FY2020Dec 2020 | $2.70B | $954M | $9.67B |
| FY2019Dec 2019 | $1.70B | $818M | $4.98B |
Repurchases in FY2025 were −10.2% versus the prior year.
About Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such a…
- Market cap
- $89.5B
- P/E (trailing)
- 18.3×
- Fiscal year end
- December
- ISIN
- US0367521038
- Reporting currency
- USD
- Data updated
- Oct 10, 2026